These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6747349

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Induction of blood 2',5'-oligoadenylate synthetase activity in mice by gastric administration of ovine IFN-tau.
    Nakajima A, Sokawa Y.
    J Interferon Cytokine Res; 2002 Mar; 22(3):397-402. PubMed ID: 12034048
    [Abstract] [Full Text] [Related]

  • 24. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
    Kol'tsov VD, Chireshkin DG, Onufrieva EK, Nurmukhametov RKh, Malinovskaia VV, Ershov FI.
    Vestn Otorinolaringol; 1996 Mar; (4):25-7. PubMed ID: 8966873
    [Abstract] [Full Text] [Related]

  • 25. In vitro and in vivo 2',5'-oligoadenylate synthetase activity induced by recombinant DNA-derived bovine interferon alpha I1 in bovine alveolar macrophages and blood mononuclear cells.
    Holland SP, Fulton RW, Short EC, Wyckoff JH, Fox JC.
    Am J Vet Res; 1991 Nov; 52(11):1779-83. PubMed ID: 1664669
    [Abstract] [Full Text] [Related]

  • 26. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases.
    Hylton W, Cayley J, Dore C, Denman AM.
    Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Alpha-interferon treatment of juvenile laryngeal papillomatosis in adults].
    Schuurman AM, van den Broek P.
    Ned Tijdschr Geneeskd; 1985 Dec 28; 129(52):2507-9. PubMed ID: 4088374
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacologic effect of recombinant human IFN-alpha, continuously released from a matrix prepared from a polyglycerol ester of fatty acids, on 2',5'-oligoadenylate synthetase activity in murine liver.
    Yamagata Y, Yuasa Y, Yamamoto K, Okamoto K, Igari Y, Iga K, Ogawa Y.
    J Interferon Cytokine Res; 2000 Feb 28; 20(2):153-60. PubMed ID: 10714550
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT, Rothko K, Klippel JH, Friedman RM, Johnston MI.
    J Exp Med; 1983 Jun 01; 157(6):2140-6. PubMed ID: 6189954
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Immunological indicators in children with laryngeal papillomatosis and possible ways of immunocorrection].
    Garashchenko TI, Markova TP, Chuvirov DG.
    Vestn Otorinolaringol; 1996 Jun 01; (4):15-8. PubMed ID: 8966870
    [Abstract] [Full Text] [Related]

  • 34. Studies with interferon-alpha in human tumors.
    Einhorn S, Strander H.
    Med Oncol Tumor Pharmacother; 1984 Jun 01; 1(2):97-9. PubMed ID: 6400035
    [Abstract] [Full Text] [Related]

  • 35. Use of interferon-alpha in laryngeal papillomatosis: eight years of the Cuban national programme.
    Deuñas L, Alcantud V, Alvarez F, Arteaga J, Benítez A, Bopuza M, Carniege L, Cartaya B, Comas C, Cotayo R, Escobar H, Fernández H, Fernández M, Fernández R, García M, Iznaga N, la O F, Márquez J, Nordet D, Pérez J, Quintero J, Redonavich A, Robeleco M, Rodríguez H, Strander H.
    J Laryngol Otol; 1997 Feb 01; 111(2):134-40. PubMed ID: 9102438
    [Abstract] [Full Text] [Related]

  • 36. [Antibodies to alpha-2A interferon in children with juvenile respiratory papillomatosis].
    Kol'tsov VD, Onufrieva EK, Chireshkin DG, Malinovskaia VV, Ershov FI.
    Vestn Otorinolaringol; 1995 Feb 01; (5):24-6. PubMed ID: 7502448
    [Abstract] [Full Text] [Related]

  • 37. [Laryngeal Papillomatosis: A Statistical Analysis of 60 Cases].
    Kurita T, Umeno H, Chitose S, Ueda Y, Mihashi R, Nakashima T.
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Mar 01; 118(3):192-200. PubMed ID: 26349334
    [Abstract] [Full Text] [Related]

  • 38. Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines.
    Gazitt Y, Ben-Bassat H, Wallach D, Revel M, Schattner A.
    Clin Immunol Immunopathol; 1984 Jan 01; 30(1):71-9. PubMed ID: 6607796
    [Abstract] [Full Text] [Related]

  • 39. Activation of 2',5'-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: dependence of biological effect on administration route.
    Rosenblum MG, Riso A, Gutterman JU.
    Cancer Chemother Pharmacol; 1986 Jan 01; 16(3):273-6. PubMed ID: 3084109
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.